HistoSonics reported the successful treatment of the first patients in WOLVERINE, a new trial evaluating the Edison ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
HistoSonics announced the first successful treatments in a study of its Edison histotripsy system for benign prostatic hyperplasia (BPH).
World’s first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 radioembolization mapping for ...
CINCINNATI (WKRC) — A groundbreaking procedure is offering new hope for men suffering from benign prostate hyperplasia (BPH), a condition affecting up to half of all men. Keith Neer, a patient who ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
Introduction: Thulium laser enucleation of the prostate (ThuLEP) and bipolar transurethral resection of the prostate (bipolar TURP) are established surgical therapy alternatives that have proved ...
DEAR MAYO CLINIC: Recently, I was diagnosed with BPH. This is all new to me, and I hope you can help me better understand the condition and how it's treated. ANSWER: Now that you've been diagnosed ...
If urinary symptoms are affecting you, consult a urologist to explore advanced, minimally invasive treatments like Prostatic Urethral Lift (UroLift). Today's BPH treatments are designed to relieve ...